Provided by Tiger Trade Technology Pte. Ltd.

Fidelity MSCI Health Care Index ETF

85.01
+0.40000.47%
Post-market: 85.100.0900+0.11%19:30 EDT
Volume:221.54K
Turnover:18.83M
Market Cap:3.55B
PE:- -
High:85.25
Open:84.62
Low:84.54
Close:84.61
52wk High:85.46
52wk Low:64.30
Shares:41.75M
Float Shares:41.75M
Volume Ratio:1.03
T/O Rate:0.53%
Dividend:1.02
Dividend Rate:1.20%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment

Simply Wall St.
·
1 hour ago

Eli Lilly (LLY) Stock Trades Below Fair Value On Cash Flow

Simply Wall St.
·
1 hour ago

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
7 hours ago

RegenXBio reshapes board with new independent director

TIPRANKS
·
8 hours ago

Merck & Co. Inc. Stock Rises 3.8%, Outperforms Peers

Dow Jones
·
8 hours ago

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
8 hours ago

Dow up 136 Points on Gains for Shares of Merck, Goldman Sachs

Dow Jones
·
10 hours ago

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
10 hours ago

Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis

TradingKey
·
11 hours ago

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
11 hours ago

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
12 hours ago

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
13 hours ago

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Yesterday

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Yesterday

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Yesterday

China's Shandong Xinhua Profit Drops on Domestic, International Competition

Reuters
·
Yesterday

China's Innovent Biologics H1 Revenue, Profit Rise on Strong Product Sales

Reuters
·
Yesterday

Austar Lifesciences H1 Profit Drops on Higher R&D Spending

Reuters
·
Yesterday

WuXi Biologics H1 Net Profit up on Margin Expansion

Reuters
·
Yesterday

Stick with Value Stocks Until Everyone Starts Talking About Them - and as of Now They're Still Under the Radar, This Wall Street Firm Says

Dow Jones
·
Yesterday